Incyte Corporation announced today it will present at the following investor conferences during the month of May:

SAN FRANCISCO -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint(R) Neuro Intervention System will be highlighted as a platform for MRI-guided drug delivery to the brain at the ...

SAN DIEGO, May 3, 2013 /PRNewswire/ -- Ambrx today entered into a collaboration agreement with Bristol-Myers Squibb (NYSE: BMY) for the discovery and development of novel antibody drug conjugates using ...

CAMBRIDGE, Mass. -- Aegerion Pharmaceuticals, Inc. , an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare ...

Mark Farrah Associates , a leading business information provider in the health insurance sector, continues to refine database products to support the analysis of health insurance business.

BUFFALO, N.Y., May 3, 2013 /PRNewswire/ -- Referencing comedian Chris Rock's observation that "the money's in the medicine," veteran money manager Keith Summers, CFA of Tricoastal Capital recommended ...

Rockwell Medical, Inc. , a fully-integrated biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with innovative products and services for the treatment of iron deficiency, ...

WASHINGTON, May 3, 2013 /PRNewswire/ -- Results from a six-month nationwide effort to educate African Americans about the risk of Sudden Cardiac Arrest (SCA) will be presented at a special session at Heart ...

SAN DIEGO and VANCOUVER, British Columbia, May 3, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced the launch of UroSketch 3D™, an application available in Apple's App Store and designed specifically ...

LYNBROOK, N.Y., May 3, 2013 /PRNewswire/ --   BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX ® in the ...

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a supplemental new drug application for SUSTIVA® , including dosing recommendations for HIV-1 infected pediatric patients three months to three years old and weighing at least 3.5 kg.

How do researchers know whether new molecules will have a positive or negative effect? How much does the technique for moving a liquid affect the results? What about testing compou

TUSTIN, Calif. -- M Line Holdings, Inc. (OTCQB:MLHC), ("M Line" or the" Company"). M Line is pleased to announce that it's new loan facility agreement with TCA Global Credit Master ...

REDWOOD CITY, Calif., May 3, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies ...

SAN DIEGO -- Zogenix, Inc. , a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results ...

Research and Markets has announced the addition of the "Drug Industry in the United States - Porter's Five Forc

Bayshore Home Health joins Hike for Hospice Palliative Care fundraiser for eighth consecutive year Invites Canadians to enter online Hospice Donation Draw that will award winning local hospice $2,000 MISSISSAUGA, ...

EMERYVILLE, Calif., May 3, 2013 /PRNewswire/ -- "Through 2017, the healthcare data analytics market is projected to grow 8-10 times as fast as the overall economy," Ken Perez, MedeAnalytics' ...

Santarus, Inc. today announced that Gerald T. Proehl, president and chief executive officer, will make presentations at the following investment conferences:

WARSAW, Ind., May 3, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal healthcare, announced that it will be participating in the Deutsche Bank Securities ...

Emergent BioSolutions Inc. today announced that it presented preclinical data on its lead bispecific ADAPTIRTM molecule, ES414, at the 9th Annual Protein and Antibody Engineering Summit , currently underway in Boston, MA.

PRINCETON, N.J., May 3, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases ...

FARMINGDALE, N.Y., May 3, 2013 /PRNewswire/ -- Misonix, Inc. (Nasdaq: MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound ...

ROCKVILLE, Md., May 3, 2013 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced the issuance ...

LAGUNA HILLS, Calif. -- Itonis, Inc. (OTC:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce that the Company's ...

TARRYTOWN, N.Y., May 3, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial and operating results for the first quarter of 2013 and provided an update on development ...

TARRYTOWN, N.Y., May 3, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families ...

ImmunoGen, Inc. , a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload antibody-drug conjugate technology, today announced that Gregory Perry, Executive Vice President and Chief Financial Officer, will present at the upcoming Credit Suisse Antibody Day in New York.

GTx, Inc. today provided a Company update and reported financial results for the first quarter of 2013.

THE WOODLANDS, Texas, May 3, 2013 /PRNewswire/ --  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, will release ...

CHICAGO, May 3, 2013 /PRNewswire/ -- Founder and CEO of Rising Medical Solutions (Rising), Jason Beans, has been named a finalist in the Ernst & Young Entrepreneur Of The Year ® 2013 program in the Midwest. The ...

Genetic Technologies Limited , is pleased to advise that it has executed an agreement with Three Rivers Provider Network, Inc. of Chula Vista, California, USA.

Medivir AB today announces that Janssen R&D Ireland and Johnson & Johnson will provide a pre-recorded webcast for investors and other interested parties on Fri

Research and Markets has announced the addition of the "The Americas Pharmaceutical & Healthcare Reports" repor

Research and Markets has announced the addition of the "Medical Equipment Quarterly Deals Analysis: M&A an

BEVERLY HILLS, Calif. -- via PRWEB - Alphatrition stunned the competition by releasing an all new Garcinia Cambogia weight loss formulation intended to stand-out in the crowd of similar products. There ...

BRENTWOOD, England, May 3, 2013 /PRNewswire/ -- World's first licensed naloxone product for use by non-healthcare profession individuals in a community setting Prenoxad Injection is a pre-filled syringe ...

BIOTIE THERAPIES CORP.         Stock Exchange Release     3 May, 2013 at 9.00 a.m. Biotie interim report 1 January - 31 March 2013; important clinical and regulatory milestones achieved Company Highlights ...

When parents refuse to immunize, physicians should not dismiss children from their practice, says the Canadian Paediatric Society in a new practice point released today. Instead, the goal should be to ...

Spherix Incorporated -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, today announced the signing of a memorandum of understanding with ChromaDex to extend ...

Cambridge, MA -- Azzur Group, LLC, an Inc. 5000 company, announced today the opening of its New England operations with an office in Cambridge, MA. The office will support the growing biotech and pharmaceutical ...

Valeant Pharmaceuticals Provides Efinconazole Update

Palo Alto, CA -- Azzur Group, LLC. an Inc. 5000 Company announced the opening of their new office in Palo Alto, CA.

Globus Medical, Inc. , a leading spinal implant manufacturer, today announced that Richard Baron, Senior Vice President and Chief Financial Officer, will participate at

AURORA, Colo., May 2, 2013 /PRNewswire/ -- The Medical Center of Aurora (TMCA) has received the American Heart Association/American Stroke Association's Get With The Guidelines ® -Stroke Gold Plus Quality ...

In the news release, Department of Health Launches New Zombie Themed Campaign to Discourage Youth from Using Fake Weed, issued 02-May-2013 by DC Department of Health over PR Newswire, we are advised by ...

Cornerstone Therapeutics Inc. today announced that it will host a conference call at 8:30 a.m. ET on Thursday, May 9, 2013, to discuss its financial results for the first quarter of 2013 ended March 31, ...

Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of AVEO Pharmaceuticals, Inc violate